IMR OpenIR
Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer
其他题名Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer
Bu Xianmin; Zhao Chenghai; Dai Xianwei
2008
发表期刊CHINESE MEDICAL JOURNAL
ISSN0366-6999
卷号121期号:10页码:952-955
摘要Pancreatic cancer is one of the malignant tumor with a very poor prognosis. Both genetic and epigenetic alterations are involved in the pathogenetic mechanisms of pancreatic cancer. Hypermethylation and subsequent loss of expression of some tumor suppressor genes and tumor-related genes occur frequently in pancreatic cancer, such as loss of expression of pl6,1 RASSF1A,2 SOCS-1,3 and hMLH14 genes were repoted.
其他摘要Pancreatic cancer is one of the malignant tumor with a very poor prognosis. Both genetic and epigenetic alterations are involved in the pathogenetic mechanisms of pancreatic cancer. Hypermethylation and subsequent loss of expression of some tumor suppressor genes and tumor-related genes occur frequently in pancreatic cancer, such as loss of expression of pl6,1 RASSF1A,2 SOCS-1,3 and hMLH14 genes were repoted.
关键词PROSTATE-CANCER GENE METHYLATION HYPERMETHYLATION TUMORIGENESIS CARCINOMA SFRP1 Wnt hypermethylation pancreatic cancer
收录类别CSCD
语种英语
CSCD记录号CSCD:3383548
引用统计
文献类型期刊论文
条目标识符http://ir.imr.ac.cn/handle/321006/157559
专题中国科学院金属研究所
作者单位中国科学院金属研究所
推荐引用方式
GB/T 7714
Bu Xianmin,Zhao Chenghai,Dai Xianwei. Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer[J]. CHINESE MEDICAL JOURNAL,2008,121(10):952-955.
APA Bu Xianmin,Zhao Chenghai,&Dai Xianwei.(2008).Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer.CHINESE MEDICAL JOURNAL,121(10),952-955.
MLA Bu Xianmin,et al."Aberrant expression of Wnt antagonist SFRP1 in pancreatic cancer".CHINESE MEDICAL JOURNAL 121.10(2008):952-955.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Bu Xianmin]的文章
[Zhao Chenghai]的文章
[Dai Xianwei]的文章
百度学术
百度学术中相似的文章
[Bu Xianmin]的文章
[Zhao Chenghai]的文章
[Dai Xianwei]的文章
必应学术
必应学术中相似的文章
[Bu Xianmin]的文章
[Zhao Chenghai]的文章
[Dai Xianwei]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。